You can buy or sell MIST and other stocks, options, ETFs, and crypto commission-free!
Milestone Pharmaceuticals Inc. Common Shares, also called Milestone Pharmaceuticals, is a biopharmaceutical company. Read More It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.
52 Week High
52 Week Low
— per share
Expected May 1, Pre-Market